ArriVent BioPharma (AVBP) Stock Chart & Stock Price History $26.63 +0.60 (+2.31%) (As of 12/24/2024 03:03 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends ArriVent BioPharma Stock Price Performance 5 Day Performance+2.07%1 Month Performance-3.16%3 Month Performance+15.23%6 Month Performance+52.35% Receive AVBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today! (Ad)Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.>> You can grab your FREE, laminated copies right here << AVBP Stock Chart for Wednesday, December, 25, 2024 AVBP Chart by TradingView ArriVent BioPharma Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/24/2024$26.03$26.63+2.31%$26.63$25.5473,607 shs$897.35 million12/23/2024$26.09$26.03-0.23%$26.28$25.32205,051 shs$877.13 million12/20/2024$25.65$26.09+1.72%$26.69$25.23662,701 shs$879.16 million12/19/2024$25.76$25.65-0.43%$26.29$25.01124,392 shs$864.33 million12/18/2024$26.92$25.76-4.31%$27.48$25.51146,467 shs$868.04 million12/17/2024$26.48$26.92+1.66%$27.55$26.4288,735 shs$907.12 million Get the Latest News and Ratings for AVBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. 12/16/2024$26.72$26.48-0.90%$27.66$26.42113,418 shs$892.30 million12/13/2024$25.88$26.72+3.25%$27.03$25.36148,278 shs$900.46 million12/12/2024$27.50$25.88-5.89%$27.53$25.83107,444 shs$872.08 million12/11/2024$28.33$27.50-2.93%$28.73$27.39106,292 shs$926.67 million12/10/2024$28.03$28.33+1.07%$28.49$27.37137,673 shs$954.64 million12/09/2024$29.26$28.03-4.20%$29.86$28.0392,007 shs$944.61 million12/06/2024$28.55$29.26+2.49%$29.86$28.85111,169 shs$985.97 million12/05/2024$29.25$28.55-2.39%$29.70$28.33184,226 shs$962.14 million12/04/2024$29.12$29.25+0.45%$29.80$28.69111,135 shs$985.73 million12/03/2024$29.56$29.12-1.49%$30.17$28.89128,731 shs$981.34 million12/02/2024$29.96$29.56-1.34%$30.41$29.25103,997 shs$996.08 million11/29/2024$29.11$29.96+2.92%$30.26$29.25161,986 shs$1.01 billion11/28/2024$29.11$29.11$29.53$28.29106,131 shs$981.01 million11/27/2024$28.74$29.11+1.29%$29.52$28.29106,131 shs$981.01 million11/26/2024$27.50$28.74+4.51%$29.16$27.15226,304 shs$968.54 million11/25/2024$27.45$27.50+0.18%$28.33$27.26416,460 shs$926.75 million Related Companies Verona Pharma Stock Chart Rhythm Pharmaceuticals Stock Chart MoonLake Immunotherapeutics Stock Chart Janux Therapeutics Stock Chart Edgewise Therapeutics Stock Chart Xenon Pharmaceuticals Stock Chart Merus Stock Chart ACADIA Pharmaceuticals Stock Chart Twist Bioscience Stock Chart MorphoSys Stock Chart Receive AVBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVBP) was last updated on 12/25/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ArriVent BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ArriVent BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVBP Stock Alerts